Liquidia (LQDA) Accumulated Expenses (2019 - 2026)
Liquidia (LQDA) posted Accumulated Expenses of $121.7 million for Q2 2026, up 38.72% on a QoQ basis from $87.7 million in Q1 2026, and up 440.36% year-over-year from $22.5 million in Q2 2025.
Analysis
Liquidia (LQDA) Accumulated Expenses (2019 - 2026) Analysis & Trends
Liquidia has reported Accumulated Expenses for 8 years, with the latest figure at $121.7 million in Q2 2026.
- On a quarterly basis, Accumulated Expenses rose 440.36% year-over-year to $121.7 million in Q2 2026; TTM through Jun 2026 was $121.7 million, a 440.36% increase from a year earlier, with the FY2025 full-year figure at $73.2 million, up 292.29% from the prior year.
- Accumulated Expenses was $121.7 million for Q2 2026 at Liquidia, up from $87.7 million in the prior quarter.
- The five-year high for Accumulated Expenses was $121.7 million in Q2 2026, with the low at $845000.0 in Q1 2022.
- Average Accumulated Expenses over 5 years is $26.4 million, with a median of $14.0 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2026: Accumulated Expenses tumbled 43.18% in 2022, then jumped 533.83% in 2026.
- Over 5 years, Accumulated Expenses stood at $5.5 million in 2022, then jumped by 142.67% to $13.4 million in 2023, then jumped by 39.25% to $18.7 million in 2024, then soared by 292.29% to $73.2 million in 2025, then surged by 66.26% to $121.7 million in 2026.
- The last three Accumulated Expenses figures came in at $121.7 million (Q2 2026), $87.7 million (Q1 2026), and $73.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.53 Bn | 625.77 Bn | 17.26 Bn |
| 2 | AbbVie | 442.27 Bn | 435.70 Bn | 12.70 Bn |
| 3 | Merck | 366.81 Bn | 359.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn |
| 5 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn |
| 6 | Sanofi | 52.46 Bn | 45.08 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.12 Bn | 44.12 Bn | - |
| 8 | Incyte | 25.49 Bn | 20.95 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.55 Bn | 18.89 Bn | 683.80 Mn |
| 10 | Liquidia | 6.09 Bn | 5.80 Bn | 160.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 121.70 Mn |
| Mar 31, 2026 | 87.73 Mn |
| Dec 31, 2025 | 73.20 Mn |
| Sep 30, 2025 | 40.44 Mn |
| Jun 30, 2025 | 22.52 Mn |
| Mar 31, 2025 | 13.84 Mn |
| Dec 31, 2024 | 18.66 Mn |
| Sep 30, 2024 | 17.04 Mn |
| Jun 30, 2024 | 13.10 Mn |
| Mar 31, 2024 | 14.07 Mn |
| Dec 31, 2023 | 13.40 Mn |
| Sep 30, 2023 | 6.62 Mn |
| Jun 30, 2023 | 14.77 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 5.52 Mn |
| Sep 30, 2022 | 5.22 Mn |
| Jun 30, 2022 | 4.31 Mn |
| Mar 31, 2022 | 845,000.00 |
| Dec 31, 2021 | 5.17 Mn |
| Sep 30, 2021 | 2.06 Mn |